Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Healthcare delivery for HIV-positive people with tuberculosis in Europe

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cardiac chamber volumes and left ventricular mass in people living with HIV and matched uninfected controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. HIV infection is associated with type 2 diabetes mellitus

    Research output: Contribution to journalLetterResearchpeer-review

  2. De novo electrocardiographic abnormalities in persons living with HIV

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
The aim of the study was to compare changes in bone mineral density (BMD) over 144 weeks in HIV-infected patients initiating nucleoside reverse transcriptase inhibitor (NRTI)-sparing or protease inhibitor-sparing highly active antiretroviral therapy (HAART).
Original languageEnglish
JournalHIV Medicine
Volume12
Issue number3
Pages (from-to)157-65
Number of pages9
ISSN1464-2662
DOIs
Publication statusPublished - 1 Mar 2011

    Research areas

  • Absorptiometry, Photon, Adult, Antiretroviral Therapy, Highly Active, Benzoxazines, Bone Density, Female, HIV Infections, HIV-1, Humans, Lamivudine, Male, Pyrimidinones, Ritonavir, Zidovudine

ID: 32773871